1. Companies
  2. Obsidian Therapeutics
  3. Team

  4. Team

Obsidian Therapeutics

Obsidian Therapeutics

Aspires to extend adoptive immunotherapy.
Launch date
Employees
51-200 people
Market cap
-
Enterprise valuation
€584—875m (Dealroom.co estimates Apr 2024.)
Cambridge Massachusetts (HQ)
http://obsidiantx.com/
https://twitter.com/obsidian_txhttps://www.linkedin.com/company/obsidian-therapeutics
View job openings
Authorizing premium user...